Transplantation of Human Amniotic Mesenchymal Stem Cells Up-Regulates Angiogenic Factor Expression to Attenuate Diabetic Kidney Disease in Rats

References

• Bikbov B, Purcell CA, Levey AS.; Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Ebaid H, Bashandy SAE, Abdel-Mageed AM, Al-Tamimi J, Hassan I, Alhazza IM. Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutr Metab. 2020;17:6. doi:10.1186/s12986-019-0419-7
   Google Scholar
• Daios S, Kaiafa G, Pilalas D, et al. Endothelial dysfunction and platelet hyperaggregation in type 2 diabetes mellitus: the era of novel anti-diabetic agents. Curr Med Chem. 2021;28(20):3935–3963. doi:10.2174/0929867327666201009143816
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kosugi T, Haneda M, Rivard CJ, Long DA. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009;58(7):1471–1478. doi:10.2337/db09-0119
   PubMed Web of Science ®Google Scholar
• Tanabe K, Maeshima Y, Sato Y, Wada J. Antiangiogenic therapy for diabetic nephropathy. Biomed Res Int. 2017;2017:5724069. doi:10.1155/2017/5724069
   PubMed Web of Science ®Google Scholar
• Wen D, Huang X, Zhang M, et al. Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PLoS One. 2013;8(12):e82336. doi:10.1371/journal.pone.0082336
   PubMed Web of Science ®Google Scholar
• Gowd V, Kang Q, Wang Q, Wang Q, Chen F, Cheng KW. Resveratrol: evidence for its nephroprotective effect in diabetic nephropathy. Adv Nutr. 2020;11(6):1555–1568. doi:10.1093/advances/nmaa075
   PubMed Web of Science ®Google Scholar
• Zhang A, Fang H, Chen J, He L, Chen Y. Role of VEGF-A and LRG1 in abnormal angiogenesis associated with diabetic nephropathy. Front Physiol. 2020;11:1064. doi:10.3389/fphys.2020.01064
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang SC. Recent progress in stem cell therapy for diabetic nephropathy. Kidney Dis. 2016;2(1):20–27. doi:10.1159/000441913
   Google Scholar
• Zang L, Hao H, Liu J, Li Y, Han W, Mu Y. Mesenchymal stem cell therapy in type 2 diabetes mellitus. Diabetol Metab Syndr. 2017;9:36. doi:10.1186/s13098-017-0233-1
   PubMed Web of Science ®Google Scholar
• Xiang E, Han B, Zhang Q, et al. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336. doi:10.1186/s13287-020-01852-y
   PubMed Web of Science ®Google Scholar
• An Y, Liu WJ, Xue P, et al. Autophagy promotes MSC-mediated vascularization in cutaneous wound healing via regulation of VEGF secretion. Cell Death Dis. 2018;9(2):58. doi:10.1038/s41419-017-0082-8
   PubMedGoogle Scholar
• Patel DB, Gray KM, Santharam Y, Lamichhane TN, Stroka KM, Jay SM. Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles. Bioeng Transl Med. 2017;2(2):170–179. doi:10.1002/btm2.10065
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hao Z, Wang P, et al. Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1alpha-mediated promotion of angiogenesis in a rat model of stabilized fracture. Cell Prolif. 2019;52(2):e12570. doi:10.1111/cpr.12570
   PubMed Web of Science ®Google Scholar
• Liu QW, Huang QM, Wu HY, et al. Characteristics and therapeutic potential of human amnion-derived stem cells. Int J Mol Sci. 2021;22:2.
   Google Scholar
• Lm Y. Complete medium and human amnion-derived mesenchymal stem cell culture method; 2011.
   Google Scholar
• Rc Z. Stem Cells: Basics and Clinical Translation. Springer Science Business Media Dordrecht; 2015.
   Google Scholar
• Brosius FC 3rd, Alpers CE, Bottinger EP, et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2009;20(12):2503–2512. doi:10.1681/ASN.2009070721
   PubMed Web of Science ®Google Scholar
• Bai Y, Wang J, He Z, Yang M, Li L, Jiang H. Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor beta (TGF-beta)/smad pathway and pro-inflammatory cytokines. Med Sci Monit. 2019;25:3069–3076. doi:10.12659/MSM.914860
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ye C, Wang G, et al. Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats. Biomed Res Int. 2013;2013:526367. doi:10.1155/2013/526367
   PubMed Web of Science ®Google Scholar
• Li S, Zou H, Gong M, et al. Angiopoietin-1 promotes the integrity of neovascularization in the subcutaneous matrigel of type 1 diabetic rats. Biomed Res Int. 2019;2019:2016972. doi:10.1155/2019/2016972
   PubMed Web of Science ®Google Scholar
• Yan ZX, Luo Y, Liu NF. Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea. Int J Ophthalmol. 2017;10(8):1187–1194. doi:10.18240/ijo.2017.08.01
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307. doi:10.1038/nature10144
   PubMed Web of Science ®Google Scholar
• An YA, Sun K, Joffin N, et al. Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesis. Elife. 2017;6:1. doi:10.7554/eLife.24071
   Web of Science ®Google Scholar
• Karalliedde J, Gnudi L. Endothelial factors and diabetic nephropathy. Diabetes Care. 2011;34:S291–296. doi:10.2337/dc11-s241
   PubMed Web of Science ®Google Scholar
• Khalaf N, Helmy H, Labib H, Fahmy I, El Hamid MA, Moemen L. Role of angiopoietins and Tie-2 in diabetic retinopathy. Electron Physician. 2017;9(8):5031–5035. doi:10.19082/5031
   PubMedGoogle Scholar
• Desideri S, Onions KL, Baker SL, et al. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy. Biorheology. 2019;56(2–3):163–179. doi:10.3233/BIR-180199
   PubMed Web of Science ®Google Scholar
• de Mayo T, Conget P, Becerra-Bayona S, Sossa CL, Galvis V, Arango-Rodriguez ML. The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice. PLoS One. 2017;12(6):e0177533. doi:10.1371/journal.pone.0177533
   PubMed Web of Science ®Google Scholar
• Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol. 2001;12(5):993–1000. doi:10.1681/ASN.V125993
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Sato W, Kosugi T, Johnson RJ. Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy. J Diabetes Res. 2013;2013:184539. doi:10.1155/2013/184539
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu J, Zou T, et al. DPSCs treated by TGF-beta1 regulate angiogenic sprouting of three-dimensionally co-cultured HUVECs and DPSCs through VEGF-Ang-Tie2 signaling. Stem Cell Res Ther. 2021;12(1):281. doi:10.1186/s13287-021-02349-y
   PubMed Web of Science ®Google Scholar
• Hou N, Huang N, Han F, Zhao J, Liu X, Sun X. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats. Int Urol Nephrol. 2014;46(10):2045–2051. doi:10.1007/s11255-014-0807-x
   PubMed Web of Science ®Google Scholar
• Shukla R, Pandey N, Banerjee S, Tripathi YB. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1alpha and vascular endothelial growth factor in kidney of diabetic rats. Biomed Pharmacother. 2017;93:276–285. doi:10.1016/j.biopha.2017.06.045
   PubMed Web of Science ®Google Scholar
• Zou X, Gu D, Xing X, et al. Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Transl Res. 2016;8(10):4289–4299.
   PubMed Web of Science ®Google Scholar
• Zhang D, Shao S, Shuai H, et al. SDF-1alpha reduces fibronectin expression in rat mesangial cells induced by TGF-beta1 and high glucose through PI3K/Akt pathway. Exp Cell Res. 2013;319(12):1796–1803. doi:10.1016/j.yexcr.2013.03.030
   PubMed Web of Science ®Google Scholar
• Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and −2. Cold Spring Harb Perspect Med. 2012;2(5):a006627. doi:10.1101/cshperspect.a006627
   PubMed Web of Science ®Google Scholar